Smokey1958 wrote: No one should be jumping to any outrageous conclusuions.
* SONA has Arlington for support, THRM has/had Nanocomposix
* Arlington is a company with 36 employees and annual revenues of $7 million
* Nanocomposix is a company with 40+ employees and annual revenues of $9 million
* THRM has backing from some American "heavy hitters" in Ridge Global
*THRM FDA EUA application started in July of this year, SONA?
* Intial sensitivity and specificity are similar ...so accuracy on par?
* As with THRM, day traders and shorters will, unfortunately, have a field day with the SONA NR?
Is THRM much farther along on the FDA EUA application process than SONA...there is no compelling argument to the contrary. One can only wish those that have SONA shares are rewarded for their patience as THRM investors will be ....imho ....but let's not presume for a minute that the no. of outstanding shares has any influence on the success of the applications.
dart321 wrote: Ya you better go read their news release. With it's 55 million shares outstanding it's going to make this company look like it's standing still with it's 250 million shares outstanding. Taking a phrase from someone else " can you say KABOOM"!!!!